FDA 483 - AVEVA Drug Delivery Systems, Inc. - July 26, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of AVEVA Drug Delivery Systems, Inc. in Miramar, FL, a manufacturer of transdermal patches and sublingual films, revealed significant issues with quality control. The firm failed to thoroughly review unexplained discrepancies and ensure batches met specifications, as evidenced by undetected manufacturing defects and inadequate investigations. Additionally, the company's appearance specifications for drug products were found to be deficient, lacking clear criteria for handling defective units.
ID · a5d313a9-e652-474f-b6cb-e57f2260ecea